Novo Nordisk A/S
NVONYSEHealthcare● Active
$41.02
$-1.94(-4.50%)
Market Cap$182.3B
P/E Ratio—
52W High$81.44
52W Low$35.12
Novo Nordisk A/S (NVO) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NVO · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $26.96B | $26.31B | $30.23B | $23.57B | $17.48B |
| Net Receivables | $75.70B | $87.41B | $75.26B | $57.51B | $46.80B |
| Inventory | $49.62B | $40.85B | $31.81B | $24.39B | $19.62B |
| Total Current Assets | $172.45B | $160.90B | $139.65B | $108.19B | $85.59B |
| PP&E Net | $208.38B | $162.49B | $90.96B | $66.67B | $55.36B |
| Goodwill | $19.84B | $20.06B | $4.46B | $5.09B | $4.35B |
| Intangible Assets | $110.21B | $91.03B | $55.94B | $46.32B | $38.83B |
| Total Assets | $542.90B | $465.80B | $314.49B | $241.26B | $194.51B |
| Liabilities | |||||
| Short-Term Debt | $12.02B | $11.78B | $5.30B | $0.48B | $12.86B |
| Accounts Payable | $19.76B | $28.85B | $25.61B | $15.59B | $8.87B |
| Total Current Liabilities | $215.66B | $217.53B | $169.66B | $120.94B | $99.52B |
| Long-Term Debt | $110.37B | $84.25B | $15.98B | $20.77B | $9.65B |
| Total Liabilities | $348.86B | $322.31B | $207.93B | $157.77B | $123.76B |
| Stockholders Equity | |||||
| Retained Earnings | $195.30B | $144.45B | $104.84B | $80.59B | $72.00B |
| Total Stockholders Equity | $194.05B | $143.49B | $106.56B | $83.49B | $70.75B |
| Total Liab & Equity(computed) | $542.90B | $465.80B | $314.49B | $241.26B | $194.51B |
| Debt Summary | |||||
| Total Debt | $130.96B | $102.79B | $27.01B | $25.78B | $26.64B |
| Net Debt | $104.49B | $87.13B | $12.61B | $13.13B | $15.93B |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · DKK · B
Explore more Novo Nordisk A/S data
About Novo Nordisk A/S (NVO) Balance Sheet
Novo Nordisk A/S (NVO) balance sheet shows total assets of $542.90B with cash of $26.96B. Total liabilities are $348.86B, total debt $130.96B, and stockholders equity $194.05B.
Frequently asked questions
NVO · 4 questionsNovo Nordisk A/S has total debt of $130.96B with net debt of $104.49B.
NVO total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10